45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
82,328
Insurances with rates
38
CPT / HCPCS codes
29,430
Source MRF
Most expensive procedures (gross)
3088581
$68,566
IMPLANT NEURORECEIVER
Gross
$76,184
3088581
$68,566
IMPLANT NEURORECEIVER
Gross
$76,184
15170017
$67,248
Autologous cultured chondrocytes, implant
Gross
$74,720
15170017
$67,248
Autologous cultured chondrocytes, implant
Gross
$74,720
3088990
$66,111
BI-VENTRICULAR ICD ATLAS II
Gross
$73,456
3088990
$66,111
BI-VENTRICULAR ICD ATLAS II
Gross
$73,456
3088991
$59,713
BI-VENTRICULAR ICD ATLAS/EPIC
Gross
$66,347
3088991
$59,713
BI-VENTRICULAR ICD ATLAS/EPIC
Gross
$66,347
14593885
$51,197
58468-0200-01 - alemtuzumab 10 mg/mL SOLN
Gross
$56,885
14593885
$51,197
58468-0200-01 - alemtuzumab 10 mg/mL SOLN
Gross
$56,885
14564167
$48,250
INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR
Gross
$53,611
14564167
$48,250
INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR
Gross
$53,611
3089097
$46,704
DEFIBRILLATOR ATLAS II
Gross
$51,893
3089097
$46,704
DEFIBRILLATOR ATLAS II
Gross
$51,893
3089113
$44,784
DUAL CHAMBER ICD
Gross
$49,760
3089113
$44,784
DUAL CHAMBER ICD
Gross
$49,760
3089212
$43,112
INSERT/REMOVE AICD
Gross
$47,902
3089212
$43,112
INSERT/REMOVE AICD
Gross
$47,902
3089342
$42,652
SINGLE CHAMBER ICD
Gross
$47,391
3089342
$42,652
SINGLE CHAMBER ICD
Gross
$47,391
14632514
$41,308
15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN
Gross
$45,898
14632514
$41,308
15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN
Gross
$45,898
15221164
$40,201
50242-0105-01 - polatuzumab vedotin 140 mg Powd
Gross
$44,667
15221164
$40,201
50242-0105-01 - polatuzumab vedotin 140 mg Powd
Gross
$44,667
3088583
$39,767
IMPLANT SPINAL INFUSION PUMP
Gross
$44,186
3088583
$39,767
IMPLANT SPINAL INFUSION PUMP
Gross
$44,186
14458355
$39,528
15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F]
Gross
$43,920
14458355
$39,528
15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F]
Gross
$43,920
15131399
$38,416
69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN
Gross
$42,685
15131399
$38,416
69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN
Gross
$42,685
14580370
$35,460
47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F]
Gross
$39,400
14580370
$35,460
47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F]
Gross
$39,400
15147404
$34,052
Impella CP Pump Set
Gross
$37,835
15147404
$34,052
Impella CP Pump Set
Gross
$37,835
2870328
$33,431
GENERATOR PULSE IMPLANT 7427
Gross
$37,146
2870328
$33,431
GENERATOR PULSE IMPLANT 7427
Gross
$37,146
14609370
$31,821
WAVELINQ ENDOVASCULAR AVF CREATION
Gross
$35,357
14609370
$31,821
WAVELINQ ENDOVASCULAR AVF CREATION
Gross
$35,357
3089213
$30,888
INSERT/REPLACE PULSE GEN
Gross
$34,320
3089213
$30,888
INSERT/REPLACE PULSE GEN
Gross
$34,320
14609873
$28,951
Vertiflex Initial Level
Gross
$32,168
14634746
$28,951
DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY
Gross
$32,168
14609873
$28,951
Vertiflex Initial Level
Gross
$32,168
14634746
$28,951
DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY
Gross
$32,168
14564166
$28,058
INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD
Gross
$31,176
14564166
$28,058
INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD
Gross
$31,176
15163786
$27,000
Shockwave IVL w/Ather/Stent/PTA Lower Ext.
Gross
$30,000
15238942
$27,000
SFA POP STENT ATHERECTOMY [F]
Gross
$30,000
15238948
$27,000
TIBIAL PERONEAL STENT/ATHERECTOMY [F]
Gross
$30,000
15163786
$27,000
Shockwave IVL w/Ather/Stent/PTA Lower Ext.
Gross
$30,000
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 3088581 | IMPLANT NEURORECEIVER | $76,184 | $68,566 | — | — | 11 |
| 3088581 | IMPLANT NEURORECEIVER | $76,184 | $68,566 | — | — | 12 |
| 15170017 | Autologous cultured chondrocytes, implant | $74,720 | $67,248 | — | — | 11 |
| 15170017 | Autologous cultured chondrocytes, implant | $74,720 | $67,248 | — | — | 12 |
| 3088990 | BI-VENTRICULAR ICD ATLAS II | $73,456 | $66,111 | — | — | 11 |
| 3088990 | BI-VENTRICULAR ICD ATLAS II | $73,456 | $66,111 | — | — | 12 |
| 3088991 | BI-VENTRICULAR ICD ATLAS/EPIC | $66,347 | $59,713 | — | — | 11 |
| 3088991 | BI-VENTRICULAR ICD ATLAS/EPIC | $66,347 | $59,713 | — | — | 12 |
| 14593885 | 58468-0200-01 - alemtuzumab 10 mg/mL SOLN | $56,885 | $51,197 | — | — | 11 |
| 14593885 | 58468-0200-01 - alemtuzumab 10 mg/mL SOLN | $56,885 | $51,197 | — | — | 12 |
| 14564167 | INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR | $53,611 | $48,250 | — | — | 11 |
| 14564167 | INSERTION/RPLCMT PERIPHERAL/GASTRIC NPGR | $53,611 | $48,250 | — | — | 12 |
| 3089097 | DEFIBRILLATOR ATLAS II | $51,893 | $46,704 | — | — | 11 |
| 3089097 | DEFIBRILLATOR ATLAS II | $51,893 | $46,704 | — | — | 12 |
| 3089113 | DUAL CHAMBER ICD | $49,760 | $44,784 | — | — | 11 |
| 3089113 | DUAL CHAMBER ICD | $49,760 | $44,784 | — | — | 12 |
| 3089212 | INSERT/REMOVE AICD | $47,902 | $43,112 | — | — | 11 |
| 3089212 | INSERT/REMOVE AICD | $47,902 | $43,112 | — | — | 12 |
| 3089342 | SINGLE CHAMBER ICD | $47,391 | $42,652 | — | — | 11 |
| 3089342 | SINGLE CHAMBER ICD | $47,391 | $42,652 | — | — | 12 |
| 14632514 | 15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN | $45,898 | $41,308 | — | — | 11 |
| 14632514 | 15054-1120-04 - lanreotide 120 mg/0.5 mL SOLN | $45,898 | $41,308 | — | — | 12 |
| 15221164 | 50242-0105-01 - polatuzumab vedotin 140 mg Powd | $44,667 | $40,201 | — | — | 11 |
| 15221164 | 50242-0105-01 - polatuzumab vedotin 140 mg Powd | $44,667 | $40,201 | — | — | 12 |
| 3088583 | IMPLANT SPINAL INFUSION PUMP | $44,186 | $39,767 | — | — | 11 |
| 3088583 | IMPLANT SPINAL INFUSION PUMP | $44,186 | $39,767 | — | — | 12 |
| 14458355 | 15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F] | $43,920 | $39,528 | — | — | 11 |
| 14458355 | 15054-1120-03 - lanreotide 120 mg/0.5 mL SOLN [F] | $43,920 | $39,528 | — | — | 12 |
| 15131399 | 69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN | $42,685 | $38,416 | — | — | 11 |
| 15131399 | 69097-0870-67 - lanreotide 120 mg/0.5 mL SOLN | $42,685 | $38,416 | — | — | 12 |
| 14580370 | 47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F] | $39,400 | $35,460 | — | — | 11 |
| 14580370 | 47335-0177-95 - tildrakizumab 100 mg/mL SOLN [F] | $39,400 | $35,460 | — | — | 12 |
| 15147404 | Impella CP Pump Set | $37,835 | $34,052 | — | — | 11 |
| 15147404 | Impella CP Pump Set | $37,835 | $34,052 | — | — | 12 |
| 2870328 | GENERATOR PULSE IMPLANT 7427 | $37,146 | $33,431 | — | — | 11 |
| 2870328 | GENERATOR PULSE IMPLANT 7427 | $37,146 | $33,431 | — | — | 12 |
| 14609370 | WAVELINQ ENDOVASCULAR AVF CREATION | $35,357 | $31,821 | — | — | 11 |
| 14609370 | WAVELINQ ENDOVASCULAR AVF CREATION | $35,357 | $31,821 | — | — | 12 |
| 3089213 | INSERT/REPLACE PULSE GEN | $34,320 | $30,888 | — | — | 11 |
| 3089213 | INSERT/REPLACE PULSE GEN | $34,320 | $30,888 | — | — | 12 |
| 14609873 | Vertiflex Initial Level | $32,168 | $28,951 | — | — | 11 |
| 14634746 | DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY | $32,168 | $28,951 | — | — | 11 |
| 14609873 | Vertiflex Initial Level | $32,168 | $28,951 | — | — | 12 |
| 14634746 | DESTRUCTION OF INTRAOSSEOUS BASIVERTEBRAL NERVE, FIRST TWO BODIES INCLUDING FLOUROSCOPY | $32,168 | $28,951 | — | — | 12 |
| 14564166 | INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD | $31,176 | $28,058 | — | — | 11 |
| 14564166 | INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD | $31,176 | $28,058 | — | — | 12 |
| 15163786 | Shockwave IVL w/Ather/Stent/PTA Lower Ext. | $30,000 | $27,000 | — | — | 11 |
| 15238942 | SFA POP STENT ATHERECTOMY [F] | $30,000 | $27,000 | — | — | 11 |
| 15238948 | TIBIAL PERONEAL STENT/ATHERECTOMY [F] | $30,000 | $27,000 | — | — | 11 |
| 15163786 | Shockwave IVL w/Ather/Stent/PTA Lower Ext. | $30,000 | $27,000 | — | — | 12 |
Showing top 50 of 82,328 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.